GSE253113 amiodarone 1 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE253113_amiodarone_1_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE253113_amiodarone_1_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE253113_amiodarone_1_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE253113_amiodarone_1_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 29

Gene

neutrophil cytosolic factor 1C (pseudogene)

Gene

rhabdomyosarcoma 2 associated transcript

Gene

cancer susceptibility 8

Gene

ribosomal protein L17 pseudogene 47

Gene

long intergenic non-protein coding RNA 2687

Gene

HLA complex group 15

Gene

uncharacterized LOC112268136

Gene

chaperonin containing TCP1 subunit 7 pseudogene 2

Gene

SNCA antisense RNA 1

  • Gene

    small nucleolar RNA host gene 29


  • Gene

    neutrophil cytosolic factor 1C (pseudogene)


  • Gene

    rhabdomyosarcoma 2 associated transcript


  • Gene

    cancer susceptibility 8


  • Gene

    ribosomal protein L17 pseudogene 47


  • Gene

    long intergenic non-protein coding RNA 2687


  • Gene

    HLA complex group 15


  • Gene

    uncharacterized LOC112268136


  • Gene

    chaperonin containing TCP1 subunit 7 pseudogene 2


  • Gene

    SNCA antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.